Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Debt / NOTE 2.750%12/0
-
Market price (% of par)
-
35.5%
-
Total 13F principal
-
$20,000,000
-
Principal change
-
-$2,560,000
-
Total reported market value
-
$7,205,000
-
Number of holders
-
3
-
Value change
-
-$2,722,000
-
Number of buys
-
2
-
Number of sells
-
3
Institutional Holders of OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 as of Q4 2017
As of 31 Dec 2017,
OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 was held by
3 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$20,000,000
in principal (par value) of the bond.
The largest 3 bondholders included
BVF INC/IL, UBS OCONNOR LLC, and Telemetry Investments, L.L.C..
This page lists
3
institutional bondholders reporting positions
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.